Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies

European Journal of Immunology

Volumn 43, Issue 10, 2013, Pages 2659-2670

  Rosado, M Manuela ^a   Gesualdo, Francesco ^a   Marcellini, Valentina ^a   Di Sabatino, Antonio ^b   Corazza, Gino Roberto ^b   Smacchia, Maria Paola ^c   Nobili, Bruno ^d   Baronci, Carlo ^a   Russo, Lidia ^a   Rossi, Francesca ^a,d   Vito, Rita De ^a   Nicolosi, Luciana ^a   Inserra, Alessandro ^a   Locatelli, Franco ^a,b   Tozzi, Alberto E ^a   Carsetti, Rita ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Asplenia; Memory B cells; Serum anti PnPS; Splenectomy; Streptococcus pneumoniae

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; ASPLENIA; CELL LOSS; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; PLASMA CELL; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEPTICEMIA; SPLENECTOMY; TETANUS; VACCINATION;

ASPLENIA; MEMORY B CELLS; SERUM ANTI-PNPS; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTE SUBSETS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFANT; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; SPLEEN; SPLENECTOMY; TETANUS; VACCINATION; YOUNG ADULT;

EID: 84885733691     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343577     Document Type: Article

References (51)

1. King, H. and Shumacker, H. B., Jr, Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann. Surg. 1952. 136: 239-242.
2. Di Sabatino, A., Carsetti, R. and Corazza, G. R., Post-splenectomy and hyposplenic states. Lancet 2011. 378: 86-97.
3. Holdsworth, R. J., Irving, A. D. and Cuschieri, A., Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br. J. Surg. 1991. 78: 1031-1038.
4. th ed). American Academy of Pediatrics, Elk Grove Village, IL, 2012, pp. 74-90.
5. Mebius, R. E. and Kraal, G., Structure and function of the spleen. Nat. Rev. Immunol. 2005. 5: 606-616.
6. Kang, Y. S., Kim, J. Y., Bruening, S. A., Pack, M., Charalambous, A., Pritsker, A., Moran, T. M. et al., The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of streptococcus pneumoniae in the marginal zone of mouse spleen. Proc. Natl. Acad. Sci. USA 2004. 101: 215-220.
7. Foote, J. B., Mahmoud, T. I., Vale, A. M. and Kearney, J. F., Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells. J. Immunol. 2012. 188: 57-67.
8. Kruetzmann, S., Rosado, M. M., Weber, H., Germing, U., Tournilhac, O., Peter, H. H., Berner, R. et al., Human immunoglobulin M memory B cells controlling streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 2003. 197: 939-945.
9. Weller, S., Faili, A., Garcia, C., Braun, M. C., Le Deist, F. F., de Saint Basile, G. G., Hermine, O. et al., CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 2001. 98: 1166-1170.
10. Weller, S., Braun, M. C., Tan, B. K., Rosenwald, A., Cordier, C., Conley, M. E., Plebani, A. et al., Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004. 104: 3647-3654.
11. Capolunghi, F., Cascioli, S., Giorda, E., Rosado, M. M., Plebani, A., Auriti, C., Seganti, G. et al., CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 2008. 180: 800-808.
12. Liu, Y. J., Oldfield, S. and MacLennan, I. C., Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur. J. Immunol. 1988. 18: 355-362.
13. Steiniger, B., Timphus, E. M., Jacob, R. and Barth, P. J., CD27+ B cells in human lymphatic organs: re-evaluating the splenic marginal zone. Immunology 2005. 116: 429-442.
14. Coignard-Biehler, H., Lanternier, F., Hot, A., Salmon, D., Berger, A., de Montalembert, M., Suarez, F. et al., Adherence to preventive measures after splenectomy in the hospital setting and in the community. J. Infect. Public. Health 2011. 4: 187-194.
15. Cadili, A. and de Gara, C., Complications of splenectomy. Am. J. Med. 2008. 121: 371-375.
16. Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices, Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb. Mortal. Wkly. Rep. 2010. 59: 1102-1106.
17. Centers for Disease Control and Prevention (CDC), Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 2012. 61: 816-819.
18. Pickering, L., Baker, C., Kimberlin, D. and Long, S., Red book: 2012 report of the committee on infectious diseases. Am. Acad. Pediatr. 2012. 29: 1-1058.
19. Nuorti, J. P., Whitney, C. G. and Centers for Disease Control and Prevention (CDC), Prevention of pneumococcal disease among infants and children-use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine-recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 2010. 59: 1-18.
20. Reinecke, G. and Pabst, R., Subsets of blood, spleen and recirculating lymphocytes in man. Clin. Exp. Immunol. 1983. 53: 672-678.
21. Carsetti, R., Rosado, M. M. and Wardmann, H., Peripheral development of B cells in mouse and man. Immunol. Rev. 2004. 197: 179-191.
22. Rosado, M. M., Scarsella, M., Pandolfi, E., Cascioli, S., Giorda, E., Chionne, P., Madonne, E. et al., Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example. Eur. J. Immunol. 2011. 41: 1800-1808.
23. Janeway, C. A., Travers, P., Walport, M. and Capra, J. D., Immunobiology: The Immune System in Health and Disease. Current Biology, Garland Science, New York, 2001.
24. World Health Organization, Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Tech. Rep. Ser. 2005. 927: 64-98.
25. Ammann, A. J., Addiego, J., Wara, D. W., Lubin, B., Smith, W. B. and Mentzer, W. C., Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N. Engl. J. Med. 1977. 297: 897-900.
26. Landgren, O., Bjorkholm, M., Konradsen, H. B., Soderqvist, M., Nilsson, B., Gustavsson, A., Axdorph, U. et al., A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to hodgkin's lymphoma. J. Intern. Med. 2004. 255: 664-673.
27. Stanford, E., Print, F., Falconer, M., Lamden, K., Ghebrehewet, S., Phin, N., Baxter, D. et al., Immune response to pneumococcal conjugate vaccination in asplenic individuals. Hum. Vaccin. 2009. 5: 85-91.
28. Musher, D. M., Ceasar, H., Kojic, E. M., Musher, B. L., Gathe, J. C., Jr, Romero-Steiner, S. and White, A. C., Jr, Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J. Infect. Dis. 2005. 191: 1063-1067.
29. Cherif, H., Landgren, O., Konradsen, H. B., Kalin, M. and Bjorkholm, M., Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 2006. 24: 75-81.
30. Llupia, A., Vilella, A., Costas, L., Diez, C., Torres, F., Yague, J., Masso, M. et al., Can the response to 23-valent pneumococcal vaccine in splenectomised patients be predicted? Vaccine 2012. 30: 2382-2386.
31. Giebink, G. S., Le, C. T. and Schiffman, G., Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides. J. Pediatr. 1984. 105: 576-582.
32. Mikoluc, B., Kayhty, H., Bernatowska, E. and Motkowski, R., Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children. Eur. J. Clin. Microbiol. Infect. Dis. 2008. 27: 923-928.
33. Smets, F., Bourgois, A., Vermylen, C., Brichard, B., Slacmuylders, P., Leyman, S. and Sokal, E., Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine. Vaccine 2007. 25: 5278-5282.
34. Mikoluc, B., Kayhty, H., Bernatowska, E. and Motkowski, R., Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children. Eur. J. Clin. Microbiol. Infect. Dis. 2008. 27: 923-928.
35. Davies, J. M., Lewis, M. P., Wimperis, J., Rafi, I., Ladhani, S., Bolton-Maggs, P. H. and British Committee for Standards in Haematology, Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British committee for standards in haematology by a working party of the haemato-oncology task force. Br. J. Haematol. 2011. 155: 308-317.
36. Shlomchik, M. J. and Weisel, F., Germinal center selection and the development of memory B and plasma cells. Immunol. Rev. 2012. 247: 52-63.
37. Manz, R. A., Cassese, G., Thiel, A. and Radbruch, A., Long-lived plasma cells survive independent of antigen. Curr. Top. Microbiol. Immunol. 1999. 246: 71-74; discussion 74-75.
38. Pichichero, M. E., Booster vaccinations: can immunologic memory outpace disease pathogenesis? Pediatrics 2009. 124: 1633-1641.
39. Truck, J., Lazarus, R., Jonsdottir, I., Klugman, K. P. and Pollard, A. J., Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present. Clin. Infect. Dis. 2012. 55: 1577-1579; author reply 1579-1581.
40. Clutterbuck, E. A., Lazarus, R., Yu, L. M., Bowman, J., Bateman, E. A., Diggle, L., Angus, B. et al., Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J. Infect. Dis. 2012. 205: 1408-1416.
41. Taillardet, M., Haffar, G., Mondiere, P., Asensio, M. J., Gheit, H., Burdin, N., Defrance, T. and Genestier, L., The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells. Blood 2009. 114: 4432-4440.
42. Capolunghi, F., Rosado, M. M., Sinibaldi, M., Aranburu, A. and Carsetti, R., Why do we need IgM memory B cells? Immunol. Lett. 2013. 152: 114-120.
43. Carsetti, R., Rosado, M. M., Donnanno, S., Guazzi, V., Soresina, A., Meini, A., Plebani, A. et al., The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 2005. 115: 412-417.
44. Lucas, M., Lee, M., Lortan, J., Lopez-Granados, E., Misbah, S. and Chapel, H., Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J. Allergy Clin. Immunol. 2010. 125: 1354-1360.e4.
45. Hussain, M., Melegaro, A., Pebody, R. G., George, R., Edmunds, W. J., Talukdar, R., Martin, S. A. et al., A longitudinal household study of streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol. Infect. 2005. 133: 891-898.
46. Goldblatt, D., Hussain, M., Andrews, N., Ashton, L., Virta, C., Melegaro, A., Pebody, R. et al., Antibody responses to nasopharyngeal carriage of streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 2005. 192: 387-393.
47. Baumgarth, N., The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 2011. 11: 34-46.
48. McCullers, J. A., Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 2006. 19: 571-582.
49. Rice, T. W., Rubinson, L., Uyeki, T. M., Vaughn, F. L., John, B. B., Miller, R. R., 3rd, Higgs, E. et al., Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit. Care Med. 2012. 40: 1487-1498.
50. Langley, J. M., Dodds, L., Fell, D. and Langley, G. R., Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002. BMC Infect. Dis. 2010. 10: 219-2334-10-219.
51. Mamani-Matsuda, M., Cosma, A., Weller, S., Faili, A., Staib, C., Garcon, L., Hermine, O. et al., The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood 2008. 111: 4653-4659.